News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
621,502 Results
Type
Article (48918)
Company Profile (162)
Press Release (572418)
Multimedia
Podcasts (99)
Webinars (18)
Section
Business (160808)
Career Advice (2176)
Deals (26995)
Drug Delivery (130)
Drug Development (65399)
Employer Resources (127)
FDA (13908)
Job Trends (12632)
News (274741)
Policy (27887)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Standard (4)
Academia (2449)
Academic (2)
Accelerated approval (38)
Adcomms (26)
Allergies (155)
Alliances (42275)
ALS (173)
Alzheimer's disease (1479)
Antibody-drug conjugate (ADC) (382)
Approvals (14266)
Artificial intelligence (629)
Autoimmune disease (270)
Automation (46)
Bankruptcy (230)
Best Places to Work (10222)
BIOSECURE Act (14)
Biosimilars (206)
Biotechnology (97)
Bladder cancer (172)
Brain cancer (57)
Breast cancer (654)
Cancer (5085)
Cardiovascular disease (438)
Career advice (1793)
Career pathing (33)
CAR-T (286)
CDC (69)
Celiac Disease (1)
Cell therapy (749)
Cervical cancer (43)
Clinical research (57478)
Collaboration (1823)
Company closure (2)
Compensation (677)
Complete response letters (69)
COVID-19 (2834)
CRISPR (97)
C-suite (1005)
Cystic fibrosis (130)
Data (6863)
Decentralized trials (3)
Denatured (24)
Depression (165)
Dermatology (74)
Diabetes (510)
Diagnostics (6226)
Digital health (57)
Diversity (10)
Diversity, equity & inclusion (34)
Drug discovery (272)
Drug pricing (206)
Drug shortages (23)
Duchenne muscular dystrophy (231)
Earnings (60257)
Editorial (60)
Employer branding (16)
Employer resources (114)
Events (109716)
Executive appointments (1007)
FDA (17179)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1582)
Gene editing (199)
Generative AI (61)
Gene therapy (576)
GLP-1 (902)
Government (4882)
Grass and pollen (7)
Guidances (383)
Healthcare (17310)
HIV (82)
Huntington's disease (49)
IgA nephropathy (93)
Immunology and inflammation (256)
Immuno-oncology (83)
Indications (158)
Infectious disease (3173)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (139)
Intellectual property (210)
Interviews (389)
IPO (11349)
IRA (50)
Job creations (2773)
Job search strategy (1513)
JPM (68)
Kidney cancer (18)
Labor market (66)
Layoffs (367)
Leadership (35)
Legal (6359)
Liver cancer (86)
Longevity (27)
Lung cancer (657)
Lymphoma (418)
Machine learning (50)
Management (46)
Manufacturing (792)
MASH (174)
Medical device (11102)
Medtech (11204)
Mergers & acquisitions (16694)
Metabolic disorders (1339)
mRNA (195)
Multiple sclerosis (175)
NASH (14)
Neurodegenerative disease (371)
Neuropsychiatric disorders (100)
Neuroscience (2808)
Neurotech (1)
NextGen: Class of 2026 (5931)
Non-profit (4209)
Now hiring (66)
Obesity (632)
Opinion (291)
Ovarian cancer (171)
Pain (198)
Pancreatic cancer (261)
Parkinson's disease (302)
Partnered (30)
Patents (413)
Patient recruitment (576)
Peanut (52)
People (55189)
Pharmaceutical (36)
Pharmacy benefit managers (33)
Phase 1 (18560)
Phase 2 (24829)
Phase 3 (18783)
Pipeline (7421)
Policy (314)
Postmarket research (2155)
Preclinical (6892)
Press Release (58)
Prostate cancer (268)
Psychedelics (58)
Radiopharmaceuticals (261)
Rare diseases (952)
Real estate (4461)
Recruiting (54)
Regulatory (21383)
Reports (34)
Research institute (2251)
Resumes & cover letters (373)
Rett syndrome (34)
RNA editing (17)
RSV (86)
Schizophrenia (152)
Series A (264)
Series B (224)
Service/supplier (5)
Sickle cell disease (106)
Special edition (20)
Spinal muscular atrophy (144)
Sponsored (43)
Startups (3313)
Stomach cancer (13)
Supply chain (107)
Tariffs (74)
The Weekly (74)
Vaccines (1104)
Venture capital (99)
Weight loss (416)
Women's health (122)
Worklife (17)
Date
Today (110)
Last 7 days (783)
Last 30 days (2686)
Last 365 days (26258)
2026 (10134)
2025 (26451)
2024 (28853)
2023 (31679)
2022 (42347)
2021 (46594)
2020 (45660)
2019 (39237)
2018 (29434)
2017 (25653)
2016 (27604)
2015 (42878)
2014 (39213)
2013 (31952)
2012 (22317)
2011 (22510)
2010 (19962)
Location
Africa (847)
Alabama (60)
Alaska (6)
Arizona (277)
Arkansas (14)
Asia (36572)
Australia (6247)
California (10807)
Canada (3189)
China (1121)
Colorado (494)
Connecticut (529)
Delaware (357)
Europe (84333)
Florida (1546)
Georgia (393)
Hawaii (4)
Idaho (52)
Illinois (974)
India (84)
Indiana (558)
Iowa (17)
Japan (475)
Kansas (119)
Kentucky (50)
Louisiana (40)
Maine (86)
Maryland (1364)
Massachusetts (8008)
Michigan (301)
Minnesota (553)
Mississippi (5)
Missouri (138)
Montana (22)
Nebraska (23)
Nevada (131)
New Hampshire (78)
New Jersey (3057)
New Mexico (19)
New York (2881)
North Carolina (1407)
North Dakota (8)
Northern California (5508)
Ohio (326)
Oklahoma (21)
Oregon (35)
Pennsylvania (2130)
Puerto Rico (18)
Rhode Island (40)
South America (1155)
South Carolina (52)
South Dakota (2)
Southern California (4175)
Tennessee (186)
Texas (1750)
United States (39142)
Utah (362)
Virginia (252)
Washington D.C. (66)
Washington State (936)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
621,502 Results for "check points health b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Deep dive: Checking in with the FDA
BioSpace
looks back at 2025 and where the FDA is going in 2026.
April 15, 2026
·
2 min read
·
Heather McKenzie
Press Releases
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
April 22, 2026
·
6 min read
Press Releases
Background Check Anxiety: 7 Myths Ruining Your Job Search
April 10, 2026
·
1 min read
Sponsored
Turn health data into impact: Browns University’s online master in biostatistics & health data science
Trained biostatisticians play a central role in clinical science and public health. Brown’s online master’s in biostatistics (health data science concentration), prepares you with a strong foundation in biostatistical and data science methods combined with rigorous training in applied skills to make critical data-driven decisions and meet the growing demand for leaders in this industry – on your schedule
April 27, 2026
·
3 min read
Press Releases
BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 7, 2026
·
4 min read
Press Releases
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
April 21, 2026
·
11 min read
Press Releases
B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health
January 12, 2026
·
4 min read
Press Releases
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
The Company’s Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under investigation for opioid use disorder, PTSD, and traumatic brain injury
April 20, 2026
·
6 min read
Press Releases
HMNC Brain Health Presented Positive Phase 2b Data at American College of Neuropsychopharmacology Annual Meeting
January 16, 2026
·
3 min read
Press Releases
Life Sciences at a Turning Point: GenAI, Digital Health, and Precision Therapies Ignite a New Era of Hyper-Growth
November 25, 2025
·
1 min read
1 of 62,151
Next
